BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Garg H, Hada RS, Gupta JC, Talwar GP, Dubey S. Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model. World J Clin Oncol 2018; 9(8): 188-199 [PMID: 30622927 DOI: 10.5306/wjco.v9.i8.188]
URL: https://www.wjgnet.com/2218-4333/full/v9/i8/188.htm
Number Citing Articles
1
Katrin Campbell, Vivienne L. Young, Braeden C. Donaldson, Matthew J. Woodall, Nicholas J. Shields, Greg F. Walker, Vernon K. Ward, Sarah L. Young. Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune ResponsesVaccines 2021; 9(5): 463 doi: 10.3390/vaccines9050463
2
Sahar Dinparvar, Emrah Sefik Abamor, Sedanur Oztav, Tugba Gul Inci, Murat Ihlamur, Malahat Baghirova, Dilek Turgut-Balik, Adil M Allahverdiyev. Evaluation of in vitro immunostimulatory and cytotoxic effects of recombinant survivin protein in combination with doxorubicin and breast cancer antigen-loaded polycaprolactone nanoparticlesNano Futures 2023; 7(3): 035001 doi: 10.1088/2399-1984/acde26
3
Qilai Cheng, Yingchen Li, Xiaohua Guo, Hongliang Li. Involvement of mTOR/Survivin signaling pathway in TUA(2β, 3β, 23-trihydroxy-urs-12-ene-28-olic acid)-induced apoptosis in human gastric cancer cell line BGC823 cellsJournal of Ethnopharmacology 2021; 267: 113437 doi: 10.1016/j.jep.2020.113437